Home » Topics » BioWorld Science

BioWorld Science
RSS

European approval for Pariet for Zollinger-Ellison syndrome

July 12, 2004

European marketing authorization for Vesicare for overactive bladder

July 12, 2004

Ampligen study in HIV/hepatitis C coinfected patients to begin

July 12, 2004

Hemantane has protective effect in MPP+ model of Parkinson's

July 12, 2004

New data confirm Lovenox is effective antithrombotic for ACS

July 12, 2004

Update on the clinical benefits of rasagiline in PD

July 12, 2004

Glucose-lowering effects of liraglutide in patients with type 2 diabetes

July 12, 2004

Antiviral nucleoside derivatives for the treatment of hepatitis C

July 9, 2004

Cellular process in cognition enhancement improved by 5-HT6 receptor antagonists

July 9, 2004

Anxiolytic effects of NK1 and CRF1 receptor antagonists in marmosets

July 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...